Amid the ongoing surge in COVID-19 cases across the country, the Drugs Controller General of India (DCGI) has given restricted emergency use authorisation to Bharat Biotech's 'Covaxin' for children between the age of 6-12 years, report sources.

Check tweet:

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)